Dexamethasone reduces IL-17 and Tim-3 expression in BALF of asthmatic mice

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 4, 2013, Pages 479-484

  Lu, Xiao Xia ^a   McCoy, Karen S ^b   Hu, Wei Kun ^c   Xu, Jia Li ^a   Wang, Hai Qin ^a   Chen, Peng ^a   Chen, He Bin ^a  

^a Wuhan Women and Children Health Care Center ^*  (China)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

asthma; corticosteroids; cytokines; Th17 cells; Tim 3

Indexed keywords

DEXAMETHASONE; HAVCR2 PROTEIN, MOUSE; INTERLEUKIN 17; VIRUS RECEPTOR;

ANIMAL; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; LUNG LAVAGE; METABOLISM; MOUSE;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; FEMALE; GENE EXPRESSION; INTERLEUKIN-17; MICE; MICE, INBRED BALB C; RECEPTORS, VIRUS;

EID: 84881281309     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1145-4     Document Type: Article

References (39)

1. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol, 2010,28: 445-489
2. Bettelli E, Korn T, Kuchroo VK. Th17: The third member of the effector T cell trilogy. Curr Opin Immunol, 2007,19(6):652-657
3. Bettelli E, Korn T, Oukka M, et al. Induction and effector functions of T (H) 17 cells. Nature, 2008,453:1051-1057
4. Oboki K, Ohno T, Saito H, et al. Th17 and allergy. Allerqol Int, 2008,57(2):121-134
5. Sun YC, Zhou QT, Yao WZ. Sputum interleukin-17 is increased and associated with airway neutrophilia in patients with severe asthma. Chin Med J, 2005,118(11): 953-956
6. Wang YH, Liu YJ. The IL-17 cytokine family and their role in allergic inflammation. Current Opinion Immunol, 2008,20(6):697-702
7. Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol, 2003,111(6):1293-1298
8. Hellings PW, Kasran A, Liu Z, et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol, 2003,28(1):42-50
9. Oda N, Canelos PB, Essayan DM, et al. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen induced allergic response. Am J Respir Crit Care Med, 2005, 171(1):12-18
10. Nakae S, Komiyama Y, Nambu A, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity, 2002,17(3):375-387
11. Wills-Karp M, Belkaid Y, Karp CL. I-Tim-izing the pathways of counter-regulation. Nat Immunol, 2003,4(11): 1050-1052
12. Kuchroo VK, Umetsu DT, Dekruyff RH, et al. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol, 2003,3(6):454-462
13. Hastings WD, Anderson DE, Kassam N, et al. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur J Immunol, 2009,39(9): 2492-2501
14. Wang F, Wan L, Zhang C, et al. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells. Immunobiology, 2009,21(5):342-349
15. Chen Y, Langrish CL, Mckenzie B, et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest, 2006,116(5):1317-1326
16. Niwa H, Satoh T, Matsushima Y, et al. Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation. Clin Immunol, 2009,132(2):184-194
17. Seki M, Oomizu S, Sakata KM, et al. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol, 2008,127(1):78-88
18. Stampfli MR, Wiley RE, Neigh GS, et al. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J Clin Invest, 1998,102(9):1704-1714
19. Yokoyama A, Hamazaki T, Ohshita A, et al. Effect of aerosolized docosahexaenoic acid in a mouse model of atopic asthma. Int Arch Allergy Immunol, 2000,123(4): 327-332
20. Chae WJ, Lee HK, Han JH, et al. Qualitatively differential regulation of T cell activation and apoptosis by T cell receptor zeta chain ITAMs and their tyrosine residues. Int Immunol, 2004,16(9):1225-1236
21. Braun CM, Huang SK, Bashian GG, et al. Corticosteroid modulation of human, antigen-specific Th1 and Th2 responses. J Allergy Clin Immunol, 1997,100(3):400-407
22. Monney L, Sabatos CA, Gaqlia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature, 2002, 415(6871):536-541
23. Sanchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol, 2003,4(11):1093-1101
24. Nakae S, Iwakura Y, Suto H, et al. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol, 2007, 81(5):1258-1268
25. Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med, 2002,53:477-498
26. Walker C, Bode E, Boer L, et al. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis, 1992,146(1):109-115
27. Robinson DS, Hamid Q, Ying S, et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med, 1992,326(5):298-304
28. McHugh SM, Deighton J, Stewart AG, et al. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy, 1995,25(9):828-838
29. Rutkowski R, Moniuszko T, Stasiak-Barmuta A, et al. CD80 and CD86 expression on LPS-stimulated monocytes and the effect of CD80 and CD86 blockade on IL-4 and IFN-gamma production in nonatopic bronchial asthma. Arch Immunol Ther Exp, 2003,51(6):421-428
30. Pappu BP, Anqkasekwinai P, Dong C. Regulatory mechanisms of helper T cell differentiation: New lessons learned from interleukin 17 family cytokines. Pharmacol Ther, 2008,117(3):374-384
31. Wakashin H, Hirose K, Maezawa Y, et al. IL-23 and Th17 cells enhance Th2-Cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med, 2008(10):1023-1032
32. Cheung PF, Wong CK, Lam CW. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes mediated allergic inflammation. J Immunol, 2008,180(8):5625-5635
33. Hu WK, Lu XX, Yang S, et al. Expression of the Th1-specific cell-surface protein Tim-3 increases in a murine model of atopic asthma. J Asthma, 2009,46(9): 872-877
34. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem pharmacol, 2003,149:1-38
35. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 2006,441(7090): 235-238
36. Manqan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 2006,441(7090):231-234
37. Vignola AM, Chanez P, Chiappara G, et al. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med, 1997,156:591-599
38. Hoshino M, Nakamura Y, Sim JJ. Expression of growth factors and remodeling of the airway wall in bronchial asthma. Thorax, 1998,53(1):21-27
39. Minshall EM, Leung DY, Martin RJ, et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol, 1997,17(3):326-333